COMANCHE BIOPHARMA CORP.

Profile

Company Names

COMANCHE BIOPHARMA CORP.

Addresses

50 BEHARRELL STREET, #50-B, CONCORD, MA 01742

Phone Numbers

617-206-3776

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$73,600,007.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-12-14 
$37,500,000.00 
$75,000,000.00 
$37,500,000.00 
Equity 
1
2021-06-28 
$36,100,007.00 
$36,100,007.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
ANTINORI 
EXECUTIVE OFFICER
GENO LLC   |  COMANCHE BIOPHARMA CORP.
ALLISON 
 
AUGUST 
EXECUTIVE OFFICER
COMANCHE BIOPHARMA CORP.
BRENDAN 
 
BULIK-SULLIVAN 
DIRECTOR
VENTUS THERAPEUTICS U.S., INC.   |  SANTA ANA BIO, INC.   |  COMANCHE BIOPHARMA CORP.
ALLYSON 
 
FELIX 
DIRECTOR
SAYSH CORP   |  COMANCHE BIOPHARMA CORP.
SCOTT 
 
GOTTLIEB 
DIRECTOR
AMERICAN PATHOLOGY PARTNERS INC   |  ASEKO INC.   |  EVOLUTION HOME STAGING LLC   |  KURE CORP.   |  MEDAVANTE INC   |  TEMPUS LABS, INC.   |  COMANCHE BIOPHARMA CORP.
DAVID 
 
GRAYZEL 
DIRECTOR
ANNOVATION BIOPHARMA, INC.   |  ARTEAUS THERAPEUTICS, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  AKRIVEIA THERAPEUTICS, LLC   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  AFFINIA THERAPEUTICS INC.   |  ATLAS VENTURE FUND XII, L.P.   |  AEROVATE THERAPEUTICS, INC.   |  XILIO THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  TRIANA BIOMEDICINES, INC.   |  ATLAS VENTURE FUND XIII, L.P.   |  COMANCHE BIOPHARMA CORP.   |  ATLAS VENTURE FUND XIV, L.P.
THOMAS 
SCOTT 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
COMANCHE BIOPHARMA CORP.
ARTHUR 
 
LEVIN 
DIRECTOR
COMANCHE BIOPHARMA CORP.   |  AVIDITY BIOSCIENCES, INC.
MUZAMMIL 
 
MANSURI 
DIRECTOR
SEQUOIA PHARMACEUTICALS INC   |  CLICK THERAPEUTICS, INC.   |  CHARM THERAPEUTICS INC.   |  COMANCHE BIOPHARMA CORP.   |  ORSOBIO, INC.   |  GALATEA BIO, INC.
CLIVE 
 
MEANWELL 
DIRECTOR
FRACTYL HEALTH, INC.   |  COMANCHE BIOPHARMA CORP.
KETAN 
 
PATEL 
DIRECTOR
INTELLEFLEX CORP   |  SHOPWELL SOLUTIONS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  RAINMAKER HOLDINGS II, LLC   |  IVENIX, INC.   |  GENOA PHARMACEUTICALS, INC.   |  NFLECTION THERAPEUTICS, INC.   |  MENLO THERAPEUTICS, INC.   |  AMPHORA MEDICAL, INC.   |  FOREST CITY REALTY TRUST, INC.   |  AZAD ALLIANCE 2019 LLC   |  AVALYN PHARMA INC.   |  RALLYBIO HOLDINGS, LLC   |  REDIRECT HEALTH, LLC   |  FOREST CITY ENTERPRISES, L.P.   |  AVIVOMED INC.   |  ABK BIOMEDICAL INC   |  FC 1275 NJ MEMBER LLC   |  FC TOD MF II HOLDINGS LLC   |  FC TOD BTR HOLDINGS I LLC   |  COMANCHE BIOPHARMA CORP.   |  LOS ANGELES BIOSCIENCES, INC.   |  RAINMAKER CAPITAL LLC
ANN 
 
TAYLOR 
DIRECTOR
UNLEARN.AI, INC.   |  COMANCHE BIOPHARMA CORP.
MICHAEL 
 
YOUNG 
EXECUTIVE OFFICER
QUADRANT RESIDENTIAL CAPITAL I, LLC   |  QUADRANT RESIDENTIAL CAPITAL II, LLC   |  QUADRANT RESIDENTIAL CAPITAL III, LLC   |  QUADRANT RESIDENTIAL CAPITAL IV, LP   |  HYDROS BOTTLE LLC   |  INTELIMAX MEDIA INC.   |  QUADRANT MEZZANINE PARTNERS LLC   |  APACHE IS HOLDINGS, LLC   |  FRONTFOUR NASHVILLE, LP   |  BETTER CHOICE CO INC.   |  CONNECTPAY, LLC   |  RABBLE HOLDINGS, INC.   |  HIRO, INC.   |  YOOMA WELLNESS INC.   |  ENDIATX, INC.   |  INGEL THERAPEUTICS, INC.   |  STANDARD URANIUM LTD.   |  TCS BLOCPOWER23 - TALE CLIMATE SOLUTIONS LLC   |  COMANCHE BIOPHARMA CORP.   |  SRX HEALTH SOLUTIONS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-01-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
2023-05-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#